Clinical Trials Logo

Filter by:
NCT ID: NCT00289978 Completed - Clinical trials for Relapsing-remitting Multiple Sclerosis

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

FREEDOMS
Start date: January 2006
Phase: Phase 3
Study type: Interventional

This study assessed the efficacy, safety, and tolerability of 2 doses of oral fingolimod (1.25 mg/day and 0.5 mg/day) compared to placebo in patients with relapsing-remitting multiple sclerosis (RRMS)

NCT ID: NCT00288847 Completed - Patella-Dislocation Clinical Trials

Functional Surface Electromyogram of Knee Extensors in Healthy Humans and Patients With Patella-dislocation.

Start date: November 2005
Phase: N/A
Study type: Observational

The activation of the knee extensors in adults after patella dislocation. The kneecap can dislocate due to an accident or also only due to an interior turn in the stretched knee joint out of its sliding bearing. E. Arendt (Arendt 2002) wrote an overview work, in which possible causes and working methods to the patella dislocation are discussed. Despite almost one hundred quotations the authors are not able find the causes and the possible treatment concepts. The study will examined healthy adults (25 female and 25 men) and 25 patients with patella dislocation by a routine applied clinical gait analysis and surface EMG (after the European SENIAM guidelines) iin the Laboratory for Gait Analysis Basel of the Children's University Hospital Basel. The combination of gait analysis and the surface EMG with Wavelet analysis may objectify possible reasons for a patella dislocation

NCT ID: NCT00288561 Completed - Clinical trials for Age-Related Macular Degeneration (ARMD)

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Start date: November 2004
Phase: Phase 2
Study type: Interventional

Ranibizumab is derived from a murine monoclonal anti- vascular endothelial growth factor (VEGF) antibody and can penetrate through the many retinal cell layers following intravitreal injection. The present study is directed towards the assessment of ranibizumab administered on the same day in combination with verteporfin in patients with subfoveal CNV secondary to ARMD

NCT ID: NCT00287118 Completed - Psoriasis Clinical Trials

A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis

Start date: October 27, 2004
Phase: Phase 4
Study type: Interventional

An open-label, multi-center study to establish psoriasis control of moderate to severe plaque psoriasis with Raptiva therapy administered subcutaneously for 24 weeks.

NCT ID: NCT00286585 Completed - Clinical trials for Coronary Artery Disease

TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality

Start date: February 2006
Phase: Phase 4
Study type: Interventional

Volatile anesthetics may provide some protection from myocardial ischemia, an effect called anesthetic preconditioning. In patients undergoing coronary artery bypass surgery, this preconditioning effect resulted in better cardiac performance, faster recovery and lower morbidity and mortality. The investigators will perform a prospective randomized multi-center study to compare volatile with total intravenous anesthesia in patients at a high cardiac risk who undergo major non-cardiac surgery.

NCT ID: NCT00286572 Completed - Diabetes Mellitus Clinical Trials

Long-term Mortality in Diabetics Undergoing Major Surgery

Start date: January 2004
Phase: N/A
Study type: Observational

Patients with CAD and diabetes mellitus have a better prognosis than patients with CAD and no diabetes mellitus. In acute coronary syndrome patients with an insulin therapy had a better survival than patients with oral antidiabetics. But there is not known wether perioperative therapy with insulin or oral antidiabetics is associated with higher risk for higher perioperative cardiac morbidity and mortality and worse long-term survival.

NCT ID: NCT00284947 Completed - Clinical trials for Kidney Transplantation

Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

Start date: January 2006
Phase: Phase 4
Study type: Interventional

The long-term use of calcineurin inhibitors (CNI) in patients who have received a kidney transplantation is associated with renal dysfunction and hypertension. The study will evaluate the safety and efficacy of replacing the calcineurin inhibitors by using basiliximab at monthly doses.

NCT ID: NCT00284934 Completed - Kidney Diseases Clinical Trials

Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

OLYMPE
Start date: December 2005
Phase: Phase 3
Study type: Interventional

This study introduces a new optimization immunosuppressive regimen associating tacrolimus at a reduced dose and enteric-coated mycophenolate sodium at an increased dose in order to slow down renal function worsening and to prevent the progression of chronic allograft nephropathy, while maintaining the same efficacy, in maintenance renal transplant recipients.

NCT ID: NCT00284440 Withdrawn - Clinical trials for Primary Open Angle Glaucoma

Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma

Start date: March 2006
Phase: N/A
Study type: Observational

The present study is designed to compare the response of choroidal blood flow to the hand-grip test in glaucoma patients with and without visual field progression.

NCT ID: NCT00284050 Completed - Clinical trials for Diabetic Macular Edema

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement

RESOLVE
Start date: October 2005
Phase: Phase 2
Study type: Interventional

This study evaluated the safety and efficacy of ranibizumab on retinal edema and visual acuity in patients with diabetic macular edema with center involvement.